FindTrial
Sign In

Study on the Influencing Factors and Drug Resistance Mechanism of BCG Vaccine Response in Bladder Cancer

Study on the Influencing Factors and Drug Resistance Mechanism of BCG Vaccine Response in Bladder Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600116807
Enrollment
Unknown
Registered
2026-01-15
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder cancer

Interventions

Observation group:N/A

Sponsors

Army Medical Center of PLA
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.The patient was pathologically diagnosed with bladder cancer; 2.The initial diagnosis was medium-high risk non-muscle-invasive bladder cancer; 3.Receive standard BCG intravesical infusion therapy (at least 6 induction treatments); 4.There are complete clinical follow-up data (>=12 months).

Exclusion criteria

Exclusion criteria: 1.Other pathological types other than bladder cancer; 2.Has a history of treatment such as chemotherapy, radiotherapy, and targeted therapy; 3.Combined with other primary malignant tumors.

Design outcomes

Primary

MeasureTime frame
Tumor recurrence;Cell Subpopulation Abundance;—

Countries

China

Contacts

Public ContactLiu Qiuli

Army Medical Center of PLA

liuqiuli900827@163.com+86 23 6872 9241

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026